HK1198690A1 - Therapeutic use of imidazopyridine derivatives - Google Patents

Therapeutic use of imidazopyridine derivatives

Info

Publication number
HK1198690A1
HK1198690A1 HK14112128.4A HK14112128A HK1198690A1 HK 1198690 A1 HK1198690 A1 HK 1198690A1 HK 14112128 A HK14112128 A HK 14112128A HK 1198690 A1 HK1198690 A1 HK 1198690A1
Authority
HK
Hong Kong
Prior art keywords
therapeutic use
imidazopyridine derivatives
imidazopyridine
derivatives
therapeutic
Prior art date
Application number
HK14112128.4A
Other languages
English (en)
Chinese (zh)
Inventor
Chantal Alcouffe
Corentin Herbert
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47630451&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1198690(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HK1198690A1 publication Critical patent/HK1198690A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK14112128.4A 2012-01-04 2014-12-02 Therapeutic use of imidazopyridine derivatives HK1198690A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1250075A FR2985185B1 (fr) 2012-01-04 2012-01-04 Utilisation en therapeutique de derives d'imidazopyridine
PCT/IB2013/050048 WO2013102860A1 (en) 2012-01-04 2013-01-03 Therapeutic use of imidazopyridine derivatives

Publications (1)

Publication Number Publication Date
HK1198690A1 true HK1198690A1 (en) 2015-05-29

Family

ID=47630451

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14112128.4A HK1198690A1 (en) 2012-01-04 2014-12-02 Therapeutic use of imidazopyridine derivatives

Country Status (24)

Country Link
US (1) US9732078B2 (ru)
EP (1) EP2800566B1 (ru)
JP (1) JP6067032B2 (ru)
KR (1) KR102046196B1 (ru)
CN (1) CN104144687B (ru)
AU (1) AU2013207082B2 (ru)
BR (1) BR112014016632A8 (ru)
CA (1) CA2860413C (ru)
CL (1) CL2014001784A1 (ru)
CO (1) CO7020916A2 (ru)
EA (1) EA027058B1 (ru)
ES (1) ES2560619T3 (ru)
FR (1) FR2985185B1 (ru)
HK (1) HK1198690A1 (ru)
IL (1) IL233493A (ru)
MA (1) MA35878B1 (ru)
MX (1) MX336340B (ru)
PH (1) PH12014501537A1 (ru)
PL (1) PL2800566T3 (ru)
SG (1) SG11201403793UA (ru)
TW (1) TWI557122B (ru)
UY (1) UY34564A (ru)
WO (1) WO2013102860A1 (ru)
ZA (1) ZA201404928B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019011116A (es) * 2017-03-22 2020-02-05 Liao Xibin Inhibidores de la tirosina quinasa de bruton.
CN115490687B (zh) * 2022-09-19 2023-10-27 国家烟草质量监督检验中心 3-苯并呋喃基硫咪唑并吡啶衍生物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2859997B1 (fr) 2003-09-18 2006-02-03 Sanofi Synthelabo Nouveaux derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant.
FR2883286B1 (fr) * 2005-03-16 2008-10-03 Sanofi Aventis Sa NOUVEAUX DERIVES D'IMIDAZO[1,5-a]PYRIDINES, INHIBITEURS DE FGFs, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
FR2896247B1 (fr) 2006-01-13 2008-02-29 Sanofi Aventis Sa Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique
EP1891955A1 (en) 2006-07-24 2008-02-27 Sanofi-Aventis Use of 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, for the preparation of a medicament intended for the treatment of degenerative joint diseases
CN1887878A (zh) 2006-07-26 2007-01-03 浙江大学 三嗪氮氧化物及合成方法和用途
FR2962437B1 (fr) 2010-07-06 2012-08-17 Sanofi Aventis Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique

Also Published As

Publication number Publication date
CA2860413C (en) 2020-02-25
BR112014016632A8 (pt) 2017-07-04
ES2560619T3 (es) 2016-02-22
CA2860413A1 (en) 2013-07-11
SG11201403793UA (en) 2014-08-28
ZA201404928B (en) 2015-10-28
KR102046196B1 (ko) 2019-11-18
CN104144687B (zh) 2017-09-05
PH12014501537A1 (en) 2014-10-08
EP2800566B1 (en) 2015-10-28
MX2014008244A (es) 2014-11-25
AU2013207082B2 (en) 2017-06-15
CN104144687A (zh) 2014-11-12
EA027058B1 (ru) 2017-06-30
KR20140107667A (ko) 2014-09-04
IL233493A0 (en) 2014-08-31
EA201491307A1 (ru) 2014-11-28
UY34564A (es) 2013-09-02
IL233493A (en) 2017-02-28
FR2985185A1 (fr) 2013-07-05
TW201333008A (zh) 2013-08-16
US9732078B2 (en) 2017-08-15
WO2013102860A1 (en) 2013-07-11
MA35878B1 (fr) 2014-12-01
AU2013207082A1 (en) 2014-07-31
BR112014016632A2 (pt) 2017-06-13
TWI557122B (zh) 2016-11-11
CO7020916A2 (es) 2014-08-11
PL2800566T3 (pl) 2016-04-29
US20140343054A1 (en) 2014-11-20
MX336340B (es) 2016-01-15
FR2985185B1 (fr) 2013-12-27
JP2015505311A (ja) 2015-02-19
CL2014001784A1 (es) 2014-10-17
EP2800566A1 (en) 2014-11-12
JP6067032B2 (ja) 2017-01-25

Similar Documents

Publication Publication Date Title
HK1186737A1 (en) Derivatives of azaindazole or diazaindazole type as medicament
HK1211930A1 (en) Haptens of risperidone and paliperidone
HK1206937A1 (en) Methods of administering pirfenidone therapy
HK1208453A1 (en) Substituted pyridopyrimidine compounds and their use as flt3 inhibitors flt3
ZA201406082B (en) Use of ccr3-inhibitors
IL234813A0 (en) Methods for increasing the efficacy of cd37-based therapy
PL3287131T3 (pl) Terapeutyczne zastosowania ektoiny
PL2875026T3 (pl) Pochodne imidazopirydyny stosowane w leczeniu cukrzycy
HK1208029A1 (en) Imidazopyridine derivatives
HK1198690A1 (en) Therapeutic use of imidazopyridine derivatives
HK1214244A1 (zh) 咪唑並吡啶衍生物
EP2817004A4 (en) BOUVARDIN DERIVATIVES AND THEIR THERAPEUTIC USES
PT2709584T (pt) Utilização sensorial dos derivados de 6-ciclopentilideno-hexano
GB201009483D0 (en) Therapeutic use of imidazopyridine compounds
GB201104632D0 (en) Use of medicament
GB201110895D0 (en) Therapeutic use
GB201212512D0 (en) Therapeutic agents
GB201210233D0 (en) Therapeutic agents